Product Name :
C3a (70-77)
Description:
C3a (70-77) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a.
CAS:
63555-63-5
Molecular Weight:
823.94
Formula:
C35H61N13O10
Chemical Name:
2-(2-{2-[2-(2-{2-[2-(2-aminopropanamido)-3-hydroxypropanamido]-3-(1H-imidazol-5-yl)propanamido}-4-methylpentanamido)acetamido]-4-methylpentanamido}propanamido)-5-[(diaminomethylidene)amino]pentanoic acid
Smiles :
CC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)C(CO)NC(=O)C(C)N)C(=O)NC(CCCN=C(N)N)C(O)=O
InChiKey:
LYTNSBOBASKUDN-UHFFFAOYSA-N
InChi :
InChI=1S/C35H61N13O10/c1-17(2)10-23(46-32(55)25(12-21-13-39-16-42-21)47-33(56)26(15-49)48-28(51)19(5)36)30(53)41-14-27(50)44-24(11-18(3)4)31(54)43-20(6)29(52)45-22(34(57)58)8-7-9-40-35(37)38/h13,16-20,22-26,49H,7-12,14-15,36H2,1-6H3,(H,39,42)(H,41,53)(H,43,54)(H,44,50)(H,45,52)(H,46,55)(H,47,56)(H,48,51)(H,57,58)(H4,37,38,40)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Girentuximab} web|{Girentuximab} Carbonic Anhydrase|{Girentuximab} Protocol|{Girentuximab} In Vivo|{Girentuximab} manufacturer|{Girentuximab} Epigenetic Reader Domain}
Shelf Life:
≥12 months if stored properly.{{Clindamycin} site|{Clindamycin} Anti-infection|{Clindamycin} Technical Information|{Clindamycin} In Vivo|{Clindamycin} manufacturer|{Clindamycin} Cancer}
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:34816786
Additional information:
C3a (70-77) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a.|Product information|CAS Number: 63555-63-5|Molecular Weight: 823.94|Formula: C35H61N13O10|Chemical Name: 2-(2-{2-[2-(2-{2-[2-(2-aminopropanamido)-3-hydroxypropanamido]-3-(1H-imidazol-5-yl)propanamido}-4-methylpentanamido)acetamido]-4-methylpentanamido}propanamido)-5-[(diaminomethylidene)amino]pentanoic acid|Smiles: CC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)C(CO)NC(=O)C(C)N)C(=O)NC(CCCN=C(N)N)C(O)=O|InChiKey: LYTNSBOBASKUDN-UHFFFAOYSA-N|InChi: InChI=1S/C35H61N13O10/c1-17(2)10-23(46-32(55)25(12-21-13-39-16-42-21)47-33(56)26(15-49)48-28(51)19(5)36)30(53)41-14-27(50)44-24(11-18(3)4)31(54)43-20(6)29(52)45-22(34(57)58)8-7-9-40-35(37)38/h13,16-20,22-26,49H,7-12,14-15,36H2,1-6H3,(H,39,42)(H,41,53)(H,43,54)(H,44,50)(H,45,52)(H,46,55)(H,47,56)(H,48,51)(H,57,58)(H4,37,38,40)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|The direct interaction of C3a(70-77) with human mononuclear leukocytes in culture results in a concentration-dependent inhibition of the generation of LIF evoked by mitogens and by the antigen SK-SD. The extent of suppression of LIF generation by C3a(70-77) is significant at concentrations of 10-7 M or higher and exceeds 75% at 10-6 M, irrespective of the stimulus. C3a (70-77) induces histamine release and degranulation of rat mast cells, promotes contraction of guinea pig ileal tissue, and enhances vascular permeability in human skin. C3a (70-77) selectively desensitizes ileal smooth muscle to C3a but not to human C5a, a related anaphylatoxin. Conversely, C3a-(70-77) is unable to contract ileal smooth muscle pretreated with natural C3a. This cross-desensitization indicates a specific interaction of C3a (70-77) with cellular C3a binding sites.|Products are for research use only. Not for human use.|